A low AMH result can feel like a countdown, especially when you are hoping for a baby now or planning for one later. But low AMH treatment is not about treating a number in isolation. It is about understanding your ovarian reserve in the context of your age, medical history, ultrasound findings, partner’s fertility, and the family you hope to build.
AMH, or anti-Mullerian hormone, is produced by small follicles in the ovaries. It gives your fertility specialist an indication of the remaining egg supply and how the ovaries may respond to stimulation medication. It does not measure egg quality directly, predict whether you can conceive naturally this month, or determine your worth, choices, or chances of becoming a parent.
For many people, the most helpful next step is not rushing into a procedure. It is having a timely, specialist-led conversation that replaces uncertainty with a clear plan.
What a low AMH result may mean
AMH levels naturally decline with age, although the rate of decline differs greatly from person to person. A low result may suggest diminished ovarian reserve, meaning fewer recruitable eggs may be available. This can be relevant when trying to conceive, considering egg freezing, or preparing for IVF.
However, AMH is only one piece of the fertility picture. A person with low AMH may still ovulate regularly and conceive without treatment. Equally, someone with a higher AMH level may face other barriers to pregnancy, such as blocked fallopian tubes, endometriosis, sperm concerns, or uterine conditions.
Age remains a stronger indicator of egg quality than AMH. As eggs age, the likelihood of chromosomal abnormalities rises, which can affect fertilization, embryo development, miscarriage risk, and the chance of a healthy pregnancy. This is why two people with the same AMH result may receive very different recommendations.
AMH values also need careful interpretation. Laboratory ranges vary, hormonal contraception can sometimes influence results, and results should be considered alongside an antral follicle count ultrasound. One test result should inform a conversation, not create a diagnosis on its own.
Low AMH treatment starts with a complete assessment
Before recommending treatment, a fertility specialist will look beyond ovarian reserve. The assessment may include menstrual and medical history, ovulation evaluation, transvaginal ultrasound with antral follicle count, and blood tests that may include FSH and estradiol. If you are trying to conceive with a partner, semen analysis and an assessment of the fallopian tubes are often equally important.
This full picture matters because treatment should address the cause of delayed conception where possible. For example, low AMH with open tubes, regular ovulation, and normal semen parameters can call for a different approach than low AMH combined with severe male-factor infertility or tubal blockage.
Your specialist should also discuss your timeline openly. Someone aged 30 who is not ready to conceive may be considering fertility preservation. Someone in their late 30s who has been trying for a year may benefit from moving more quickly. There is no single path that fits every result.
Can AMH be increased?
There is no proven medication, supplement, or diet that permanently restores ovarian reserve or reliably raises the number of eggs available. This can be difficult to hear, particularly when online advice promises to improve AMH quickly.
Some supplements are sometimes discussed in fertility care, but they should not be started as a substitute for assessment or without medical guidance. Their benefits can depend on the individual, and some may interact with existing medications or health conditions. A change in an AMH laboratory value does not necessarily mean a meaningful improvement in egg number or pregnancy potential.
That said, caring for your overall health still matters. Avoiding smoking, maintaining a weight that supports regular ovulation, managing chronic conditions, taking folic acid before pregnancy, sleeping adequately, and limiting alcohol can support preconception health. These measures are valuable, but they are not a cure for diminished ovarian reserve.
Treatment options depend on your goals
Trying naturally or with timed guidance
If you are ovulating, have no major additional fertility factor, and have been trying for a relatively short time, your specialist may recommend a defined period of trying naturally with guidance on timing intercourse. This may be appropriate for some younger patients, but it should come with a review point rather than open-ended waiting.
Ovulation induction may be considered when ovulation is irregular. It is not designed to reverse low AMH, but it can help support ovulation in the right clinical situation.
IUI for selected circumstances
Intrauterine insemination, or IUI, places prepared sperm into the uterus around ovulation. It may be considered when the fallopian tubes are open and sperm parameters are suitable, particularly for unexplained infertility, mild male-factor concerns, or certain ovulation issues.
With low AMH, IUI is not automatically the best or worst option. Its suitability depends on age, duration of infertility, ovarian response, sperm quality, and whether there are other factors that make IVF more efficient. A clear discussion about the number of IUI cycles to consider can help prevent treatment from becoming emotionally and financially draining without a reassessment.
IVF and individualized ovarian stimulation
IVF may be recommended when time is a major concern, the tubes are blocked, sperm factors are significant, previous lower-intensity treatment has not worked, or a greater chance per treatment cycle is needed. During IVF, medication encourages multiple follicles to mature, eggs are collected, fertilized in the laboratory, and resulting embryos may be transferred fresh or frozen for a later transfer.
For patients with low AMH, an individualized stimulation protocol is especially important. The goal is not necessarily to produce a very high egg number. It is to use medication thoughtfully, optimize the response that is possible, and create a plan that reflects your priorities.
A lower egg yield can mean fewer embryos available from one cycle, and some patients may consider more than one retrieval to build a chance of having a child now or in the future. Yet low AMH does not mean IVF cannot work. Outcomes depend heavily on age, egg and sperm factors, embryo development, uterine health, and laboratory quality.
Embryo testing and frozen embryo transfer
Preimplantation genetic testing, or PGT, may be discussed for patients with known inherited genetic conditions, certain chromosome-related concerns, or recurrent pregnancy loss in selected circumstances. It is not a universal solution for low AMH. When only a small number of embryos are expected, the advantages and limitations deserve particularly careful discussion.
Embryo cryopreservation and frozen embryo transfer can provide flexibility when suitable embryos are available. A frozen transfer allows the uterine lining to be prepared in a separate cycle, which may be preferable for some patients based on their medical needs and treatment response.
Egg freezing when pregnancy is not yet planned
If you are not ready to conceive but have learned that your ovarian reserve is low, egg freezing may be worth discussing promptly. It cannot guarantee a future baby, and the number of eggs retrieved may be lower than expected with reduced reserve. Still, freezing eggs at a younger age may preserve options that could be meaningful later.
For people facing chemotherapy, ovarian surgery, or other treatment that could affect fertility, fertility preservation should be discussed as early as possible. Depending on timing and medical advice, options may include egg freezing, embryo freezing, ovarian tissue cryopreservation, or sperm preservation.
Questions worth bringing to your consultation
A good fertility consultation should leave room for both clinical facts and personal concerns. Ask what your AMH result means alongside your age and ultrasound findings, whether there are additional causes of infertility to investigate, and what timeline is reasonable for your situation. You may also want to ask what response is realistically expected from IVF, whether more than one retrieval might be considered, and how treatment decisions will change if a cycle does not go as hoped.
It is reasonable to ask about costs, medication, monitoring, emotional support, and the practical demands of each option. Fertility treatment can involve difficult decisions, and you deserve explanations that are clear enough to make those decisions with confidence.
Moving forward with clarity and hope
A low AMH result may change how urgently you approach fertility care, but it does not tell the whole story of your reproductive future. The most constructive response is timely evaluation, realistic counseling, and a plan built around your health, your timeline, and your hopes.
At IVcare Fertility in Petaling Jaya, specialist-led care can help turn a complex result into understandable next steps, whether you are trying to conceive, considering IVF, or preserving fertility for the future. Hope is not found in ignoring uncertainty. It grows when you are supported with honest guidance and care that recognizes your journey as uniquely your own.
